Allon Receives Michael J. Fox Foundation Grant For Parkinson’s Disease Research
Allon Receives Michael J. Fox Foundation Grant For Parkinson’s Disease Research
Allon Therapeutics Inc. announced this week it has received a major grant from the Michael J. Fox Foundation (MJFF) for Parkinson’s Research to conduct pre-clinical research that will help determine the potential of the Company’s lead neuroprotective drug, davunetide, as a treatment for Parkinson’s disease (PD). The newly funded research project will focus on the impact of davunetide on a key …
Read more on Medical News Today
